Zions Bancorporation N.A. Sells 256 Shares of Balchem Co. (NASDAQ:BCPC)

Zions Bancorporation N.A. lowered its holdings in Balchem Co. (NASDAQ:BCPC) by 2.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,720 shares of the basic materials company’s stock after selling 256 shares during the period. Zions Bancorporation N.A.’s holdings in Balchem were worth $1,747,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the business. Segall Bryant & Hamill LLC raised its holdings in Balchem by 8.5% during the 4th quarter. Segall Bryant & Hamill LLC now owns 36,616 shares of the basic materials company’s stock valued at $5,968,000 after acquiring an additional 2,865 shares during the period. Congress Wealth Management LLC DE lifted its holdings in Balchem by 5.0% during the 4th quarter. Congress Wealth Management LLC DE now owns 50,711 shares of the basic materials company’s stock worth $8,266,000 after purchasing an additional 2,393 shares in the last quarter. Vanguard Group Inc. boosted its stake in Balchem by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 3,961,487 shares of the basic materials company’s stock worth $645,703,000 after purchasing an additional 42,693 shares during the period. LPL Financial LLC grew its holdings in Balchem by 9.9% during the 4th quarter. LPL Financial LLC now owns 18,242 shares of the basic materials company’s stock valued at $2,943,000 after buying an additional 1,636 shares in the last quarter. Finally, Fox Run Management L.L.C. bought a new stake in shares of Balchem during the fourth quarter valued at about $866,000. 87.91% of the stock is currently owned by hedge funds and other institutional investors.

Balchem Trading Down 0.7 %

Shares of BCPC stock opened at $163.33 on Wednesday. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The firm has a market cap of $5.31 billion, a P/E ratio of 41.56, a price-to-earnings-growth ratio of 4.41 and a beta of 0.63. The business has a 50-day moving average price of $164.97 and a two-hundred day moving average price of $169.31. Balchem Co. has a 12-month low of $137.69 and a 12-month high of $186.03.

Balchem (NASDAQ:BCPC) last issued its earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). The business had revenue of $240.00 million during the quarter, compared to analysts’ expectations of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. Equities analysts anticipate that Balchem Co. will post 4.64 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on BCPC. HC Wainwright restated a “buy” rating and issued a $190.00 price objective on shares of Balchem in a research report on Monday, February 24th. StockNews.com lowered shares of Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Finally, Sidoti upgraded Balchem to a “hold” rating in a research report on Tuesday, February 25th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.